相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic modulation of immunotherapy and implications in head and neck cancer
Liye Zhou et al.
CANCER AND METASTASIS REVIEWS (2021)
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel
Daniele Caracciolo et al.
CANCERS (2021)
Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase
Chao J. Wang et al.
CANCER LETTERS (2021)
FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia
Jun Long et al.
BLOOD (2020)
HDAC Inhibitors in Acute Myeloid Leukemia
Edurne San Jose-Eneriz et al.
CANCERS (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Obesity accelerates murine gastric cancer growth by modulating the Sirt1/YAP pathway
Hai-Jun Li et al.
ONCOLOGY LETTERS (2017)
A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma
Yoshiaki Ogawa et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Nuclear accumulation of Yes-Associated Protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression
Kai Ma et al.
CANCER LETTERS (2016)
Hippo pathway and protection of genome stability in response to DNA damage
Dafni E. Pefani et al.
FEBS JOURNAL (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo
Hui Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Acute myeloid leukemia: a comprehensive review and 2016 update
I. De Kouchkovsky et al.
BLOOD CANCER JOURNAL (2016)
Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene
Lingbo Wang et al.
ONCOTARGET (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells
Ling Li et al.
CELL STEM CELL (2014)
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini et al.
NATURE MEDICINE (2014)
Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53
Nan Bai et al.
CANCER BIOLOGY & THERAPY (2013)
Emerging roles of TEAD transcription factors and its coactivators in cancers
Ajaybabu V. Pobbati et al.
CANCER BIOLOGY & THERAPY (2013)
The Hippo pathway: regulators and regulations
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
YAP oncogene overexpression supercharges colon cancer proliferation
Joseph Avruch et al.
CELL CYCLE (2012)
Histone deacetylase complexes as caretakers of genome stability
Robert S. Lahue et al.
EPIGENETICS (2012)
Yes-Associated Protein Regulation of Adaptive Liver Enlargement and Hepatocellular Carcinoma Development in Mice
Marta A. Kowalik et al.
HEPATOLOGY (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Akt associates with nuclear factor κB and plays an important role in chemoresistance of gastric cancer cells
Liang-Liang Yu et al.
ONCOLOGY REPORTS (2010)
YAP At the crossroad between transformation and tumor suppression
Efrem Bertini et al.
CELL CYCLE (2009)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
The tetramer structure of the Nervy homology two domain, NHR2, is critical for AM1/ETO's activity
YZ Liu et al.
CANCER CELL (2006)
分享论文
